The use of neutralizing antibodies to demonstrate the role of transforming growth factor-beta and Amadori-glycated albumin as mediators of experimental diabetic kidney disease.

Source:http://linkedlifedata.com/resource/pubmed/id/8744057

Download in:

View as

General Info

PMID
8744057